Trademark: 79182843
Word
RESISTANCE +
Status
Dead
Status Code
709
Status Date
Friday, December 29, 2023
Serial Number
79182843
Registration Number
5220219
Registration Date
Tuesday, June 13, 2017
Mark Type
5
Filing Date
Monday, November 30, 2015
Published for Opposition
Tuesday, March 28, 2017
Cancellation Date
Friday, December 29, 2023

Trademark Owner History
SpeeDx Pty Ltd - Original Registrant

Classifications
5 Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens for medical and veterinary purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes; medical kits in this class consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
1 Chemicals used in industry, science, photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants in this class for non-medical purposes; enzymes for industrial purposes, namely, for use in the biotechnology industry; nucleic acid sequences, other than medical and veterinary purposes; nucleic recombinant acids; acids, namely, inorganic acids; organic acids for use in the biotechnology industry; DNA polymerase, other than medical and veterinary purposes; chemicals used in food processing and screening; chemicals used in environmental monitoring
10 Surgical, medical and veterinary apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposes, namely, for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; point of care medical devices for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; medical screening apparatus in this class for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy
RESISTANCE PLUS
Color is not claimed as a feature of the mark.

Trademark Events
Mar 1, 2016
Non-Final Action Written
Feb 22, 2016
Sn Assigned For Sect 66a Appl From Ib
Feb 23, 2016
New Application Office Supplied Data Entered
Feb 27, 2016
Application Filing Receipt Mailed
Feb 29, 2016
Assigned To Examiner
Sep 16, 2016
Final Refusal E-Mailed
Mar 2, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Mar 2, 2016
Refusal Processed By Mpu
Mar 2, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Mar 19, 2016
Refusal Processed By Ib
Sep 2, 2016
Teas Response To Office Action Received
Sep 10, 2016
Assigned To Lie
Sep 15, 2016
Correspondence Received In Law Office
Sep 15, 2016
Teas/Email Correspondence Entered
Sep 16, 2016
Final Refusal Written
Sep 16, 2016
Notification Of Final Refusal Emailed
Feb 1, 2017
Approved For Pub - Principal Register
Dec 1, 2016
Limitation Of Goods Received From Ib
Dec 16, 2016
New Representative At Ib Received
Jan 23, 2017
Limitation From The Ib - Request Exam Review
Feb 1, 2017
Previous Allowance Count Withdrawn
Feb 1, 2017
Examiners Amendment -Written
Feb 1, 2017
Examiner's Amendment Entered
Feb 1, 2017
Examiners Amendment E-Mailed
Feb 1, 2017
Notification Of Examiners Amendment E-Mailed
Feb 22, 2017
Law Office Publication Review Completed
Feb 7, 2017
Final Refusal Written
Feb 7, 2017
Final Refusal E-Mailed
Feb 7, 2017
Notification Of Final Refusal Emailed
Feb 10, 2017
New Representative At Ib Received
Feb 13, 2017
Examiners Amendment -Written
Feb 13, 2017
Examiners Amendment E-Mailed
Feb 13, 2017
Notification Of Examiners Amendment E-Mailed
Feb 13, 2017
Examiner's Amendment Entered
Feb 13, 2017
Approved For Pub - Principal Register
Mar 8, 2017
Notification Of Notice Of Publication E-Mailed
Mar 28, 2017
Published For Opposition
Mar 28, 2017
Official Gazette Publication Confirmation E-Mailed
Sep 13, 2017
Final Disposition Notice Created, To Be Sent To Ib
Sep 20, 2017
Final Disposition Processed
Jun 13, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Mar 10, 2017
New Representative At Ib Received
Jun 13, 2017
Registered-Principal Register
Sep 20, 2017
Final Disposition Notice Sent To Ib
Oct 28, 2017
Final Decision Transaction Processed By Ib
Sep 6, 2024
Total Invalidation Of Reg Ext Protection Sent To Ib
Sep 6, 2024
Invalidation Processed
Aug 30, 2024
Total Invalidation Of Reg Ext Protection Created
Dec 29, 2023
Cancelled Section 71

Trademark Alertz updated from USPTO on 2030-01-24